Provexis plc (GB:PXS) has released an update.
Provexis plc, the innovative developer of the heart-healthy Fruitflow® ingredient, has announced its total number of ordinary shares and voting rights stands at 2,262,945,255. The company has been gaining attention with its patented natural ingredient, which is recognized for aiding cardiovascular health by maintaining normal blood flow. Provexis continues to expand its market presence, especially in China through a significant partnership with BYHEALTH, and sells Fruitflow directly through various online platforms.
For further insights into GB:PXS stock, check out TipRanks’ Stock Analysis page.
